Why the study?
Does the presence of proliferative retinopathy in insulin-dependent diabetic patients affect vascular reactivity to ischemia?
Does the presence of proliferative retinopathy in insulin-dependent diabetic patients affect vascular reactivity to ischemia?
Insulin-dependent diabetic patients with proliferative retinopathy exhibit impaired vascular reactivity to ischemia, suggesting that microangiopathy and neuropathy contribute to delayed vasodilation.
Associates proliferative retinopathy with impaired post-ischemic vasodilation in diabetes; leaves open causal mechanisms and clinical relevance.
To investigate vascular responses in insulin-dependent diabetic patients both with and without retinopathy, we have assessed vasodilation by forearm transcutaneous pO2 measurement after 10 min of ischemia produced by a sphygmomanometer cuff. Diabetic patients with proliferative retinopathy had a delayed vasodilatory response at 60 s (mean +/- SD pO2 = 9 +/- 3 mm Hg) compared with those having diabetes without retinopathy (15 +/- 4 mm Hg, P less than 0.01) and matched normal subjects (14 +/- 4 mm Hg, P less than 0.01). Recently diagnosed insulin-dependent diabetic patients had a very similar response (15 +/- 5 mm Hg) to matched normal subjects (15 +/- 3 mm Hg). The diminished vascular reactivity may be a consequence of microangiopathy and neuropathy, although patients with an impaired vascular response might be particularly at risk from the development of capillary closure.
No takes yet. Share an insight, caveat, or question.
Haitas et al. (1984) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: